Management of psoriasis as a systemic disease: What is the evidence?
CONCLUSIONS: Results from ongoing prospective studies on the effects of biologics on markers of systemic inflammation in patients with psoriasis will strengthen the clinical evidence base that can be used to inform treatment decisions for patients with moderate-to-severe psoriasis.
PMID: 31225638 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Korman NJ Tags: Br J Dermatol Source Type: research
More News: Alcoholism | Arthritis | Cardiology | Cardiovascular | Dermatology | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Heart | Inflammatory Bowel Disease | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Study | UK Health | Urology & Nephrology
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024